本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nuvation Bio, Inc.

5.78
-0.0200-0.34%
盤後5.810.0300+0.52%16:56 EDT
成交量:278.02萬
成交額:1,597.14萬
市值:20.29億
市盈率:-13.18
高:5.82
開:5.80
低:5.66
收:5.80
52周最高:9.75
52周最低:2.99
股本:3.51億
流通股本:2.64億
量比:0.43
換手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):-0.4387
每股收益(LYR):-0.6000
淨資產收益率:-47.81%
總資產收益率:-12.36%
市淨率:7.99
市盈率(LYR):-9.63

資料載入中...

2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/06

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/26

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/10

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/12

重要事件披露

Form 8-K - Current report